NCT02578329

Brief Summary

The purpose of this study is to determine whether a Mediterranean Diet, personalized in terms of total calories, total lipids and balanced in terms of saturated, mono- and poly-unsaturated lipids, corrects the adverse fatty acid profile of patients with CHD and reduces markers of oxidative stress and inflammation more effectively than a low-fat dietary advice.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for not_applicable coronary-artery-disease

Timeline
Completed

Started Jul 2015

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2015

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

July 23, 2015

Completed
3 months until next milestone

First Posted

Study publicly available on registry

October 16, 2015

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2017

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2018

Completed
Last Updated

June 7, 2016

Status Verified

June 1, 2016

Enrollment Period

2.3 years

First QC Date

July 23, 2015

Last Update Submit

June 6, 2016

Conditions

Keywords

Mediterranean dietblood fatty acidCoronary Artery Disease

Outcome Measures

Primary Outcomes (1)

  • Change of whole blood fatty acid profile

    Urinary isoprostanes (8-iso-PGF2-alpha will be measured at randomization and after dietary intervention by liquid chromatography-tandem mass spectrometry (LC-MS/MS) methods.

    three months

Secondary Outcomes (7)

  • Effect of Mediterranean diet on urinary isoprostanes

    three months

  • Effect of Mediterranean diet on oxidized glutathione

    three months

  • Effect of Mediterranean diet on reduced glutathione

    three months

  • Effect of Mediterranean diet on plasma Vitamin E

    three months

  • Effect of Mediterranean diet on Low-grade systemic inflammatory status

    three months

  • +2 more secondary outcomes

Study Arms (2)

Med Diet

EXPERIMENTAL

Intensively advised Mediterranean diet

Behavioral: Intensively advised Mediterranean diet

Low Fat diet

ACTIVE COMPARATOR

usual low-fat dietary advice

Behavioral: usual low-fat dietary advice

Interventions

Mediterranean Diet: fatty fish 3 times/week; legumes 2-3 times/week; vegetables twice/day; fresh fruits twice/day; 30 to 45g olive oil/day; 1-2 glasses red wine/day; less than 150g red meat/week

Med Diet

usual low-fat dietary advice for cardiovascular disease

Low Fat diet

Eligibility Criteria

Age30 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • clinical diagnosis of coronary artery disease
  • recent history of a first coronary revascularization
  • at least 60 days after any coronary procedure or event
  • age between 30 and 75 years

You may not qualify if:

  • diagnosis of diabetes mellitus
  • food intolerance to any component of the mediterranean diet
  • BMI \< 19 or \> 33
  • assuming drugs or food supplements with omega-3 fatty acids or natural or synthetic antioxidants.
  • patients already adherent to a full mediterranean diet

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro Cardiologico Monzino, IRCCS

Milan, MI, 20138, Italy

RECRUITING

MeSH Terms

Conditions

Coronary Artery Disease

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Central Study Contacts

Fabrizio Veglia, PhD

CONTACT

Monica G Giroli, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

July 23, 2015

First Posted

October 16, 2015

Study Start

July 1, 2015

Primary Completion

October 1, 2017

Study Completion

February 1, 2018

Last Updated

June 7, 2016

Record last verified: 2016-06

Locations